Positive airway pressure therapy may delay cognitive decline in adults with obstructive sleep apnea, but more research is needed, according to a systematic review published in Neurology.
“Although recent work has identified [obstructive sleep apnea] as a potentially modifiable risk factor for cognitive decline and dementia, relationships between positive airway pressure therapy — the gold standard [obstructive sleep apnea] therapy — and neurocognitive disorders are poorly understood,” Monica Moon Shieu, PhD, MS, of the department of neurology’s division of sleep